Shares of McKesson Corp. MCK slipped 1.92% to $640.66 Wednesday, on what proved to be an all-around mixed trading session for ...

Shares of McKesson Corp. MCK advanced 1.05% to $650.43 Friday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index SPX rising 2.13% to 5,638.94 and ...

McKesson (MCK) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

McKesson (MCK) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock.

GS1 US® will host a free, 45-minute interactive webinar with leaders from McKesson and Target exploring how both companies are using Electronic Product Code Information Services (EPCIS) to drive ...

As of early March 2025, investors—and consumers—have once again begun to feel skittish about the possibility of an impending ...

In early January, the company formerly known as AmerisourceBergen, which owns and operates Besse Medical, purchased Retina ...

The global clinical informatics market, valued at US$ 198.33 Billion in 2023, is forecasted to grow at a robust CAGR of 16.0% ...

Ben Worthen of The Wall Street Journal, interviewed Randall Spratt, chief information officer at McKesson Corp. McKesson was ...

Wellysis, a pioneering digital healthcare company spun off from Samsung SDS, announces the appointment of Dominic P. Renda Jr. as Chief Commercial Officer (CCO). In this newly created role, Renda will ...